| Product Code: ETC7918002 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import of Paracetamol IV into Latvia saw significant growth in 2024, with top exporting countries being Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the increase in imports, the market concentration measured by HHI remained low, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 8.6%, with a notable growth rate of 7.03% from 2023 to 2024. This data suggests a steady demand for Paracetamol IV in Latvia, driven by imports from a diverse range of countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Paracetamol IV Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Paracetamol IV Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Paracetamol IV Market - Industry Life Cycle |
3.4 Latvia Paracetamol IV Market - Porter's Five Forces |
3.5 Latvia Paracetamol IV Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Latvia Paracetamol IV Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Paracetamol IV Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Latvia Paracetamol IV Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases and chronic conditions requiring intravenous (IV) administration of paracetamol in Latvia |
4.2.2 Growing awareness among healthcare professionals about the benefits of using IV paracetamol for pain management |
4.2.3 Rising healthcare expenditure and investments in hospital infrastructure in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of IV paracetamol products in Latvia |
4.3.2 Competition from alternative pain management medications and therapies in the market |
5 Latvia Paracetamol IV Market Trends |
6 Latvia Paracetamol IV Market, By Types |
6.1 Latvia Paracetamol IV Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Latvia Paracetamol IV Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Latvia Paracetamol IV Market Revenues & Volume, By Pain, 2021- 2031F |
6.1.4 Latvia Paracetamol IV Market Revenues & Volume, By Pyrexia (Fever), 2021- 2031F |
6.2 Latvia Paracetamol IV Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Paracetamol IV Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.3 Latvia Paracetamol IV Market Revenues & Volume, By Non-surgical, 2021- 2031F |
6.3 Latvia Paracetamol IV Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Latvia Paracetamol IV Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Latvia Paracetamol IV Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Latvia Paracetamol IV Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Paracetamol IV Market Import-Export Trade Statistics |
7.1 Latvia Paracetamol IV Market Export to Major Countries |
7.2 Latvia Paracetamol IV Market Imports from Major Countries |
8 Latvia Paracetamol IV Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities adopting IV paracetamol for pain management |
8.2 Patient satisfaction and outcomes related to the use of IV paracetamol |
8.3 Rate of adoption of IV paracetamol in different medical specialties and departments in Latvia |
9 Latvia Paracetamol IV Market - Opportunity Assessment |
9.1 Latvia Paracetamol IV Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Latvia Paracetamol IV Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Paracetamol IV Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Latvia Paracetamol IV Market - Competitive Landscape |
10.1 Latvia Paracetamol IV Market Revenue Share, By Companies, 2024 |
10.2 Latvia Paracetamol IV Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |